UNSW Sydney Secures $17 Million to Combat Cervical Cancer in South Pacific

SYDNEY, Nov. 1 (Xinhua) — The University of New South Wales (UNSW) Sydney has received a groundbreaking donation aimed at significantly improving cervical cancer screening and treatment in the South Pacific region.

This generous donation, amounting to 25.9 million Australian dollars (17.04 million U.S. dollars), is the largest ever received by UNSW Sydney. It has been made by the global conglomerate Swire Group and will empower the university’s renowned health research institute, the Kirby Institute, to make a tangible difference in the lives of over 130,000 women.

Targeting a Preventable Disease

Cervical cancer, a disease primarily caused by the human papillomavirus (HPV), continues to pose a significant health challenge in the South Pacific. With 99 percent of cases linked to HPV infection, early detection is crucial. Since most women with HPV infection don’t experience symptoms, regular screening is vital for identifying abnormal cells and preventing the development of the disease.

The Kirby Institute will collaborate with regional partners to implement cervical cancer screening programs, leveraging the success of the government-funded National Cervical Screening Program in Australia. This program, introduced in 1991, has resulted in a remarkable 50% reduction in both cervical cancer incidence and mortality rates.

This transformative donation represents a significant step forward in the global fight against cervical cancer. By investing in screening and treatment initiatives, the UNSW Sydney and the Kirby Institute are making a powerful commitment to improving the health and well-being of women across the South Pacific.

**Learn More:** To find out how you can support cervical cancer screening and prevention efforts, visit the Kirby Institute website or contact your local health authority.